5:13 PM ET
8-K
Stock Plan Amendment
Tevogen Stock Plan Amendment
Tevogen Inc. granted performance-based restricted stock awards to its CEO Ryan Saadi (8,000,000 shares) and CFO Kirti Desai (750,000 shares) under the 2024 Omnibus Incentive Plan. Vesting is contingent upon the company achieving a $1.0 billion aggregate revenue threshold by September 30, 2031. The grants are intended to align executive compensation with long-term growth and stockholder value creation.
- Term
- through Sep 2031